Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...
में बचाया:
| मुख्य लेखकों: | Vera G. Kalugina, Elena A. Vishneva, Leyla S. Namazova-Baranova |
|---|---|
| स्वरूप: | लेख |
| भाषा: | रूसी |
| प्रकाशित: |
Union of pediatricians of Russia
2020-08-01
|
| श्रृंखला: | Педиатрическая фармакология |
| विषय: | |
| ऑनलाइन पहुंच: | https://www.pedpharma.ru/jour/article/view/1858 |
| टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
समान संसाधन
-
Results of Therapy Including Omalizumab in Adolescents With Recurrent Urticaria: Retrospective Cohort Study
द्वारा: Vera G. Kalugina, और अन्य
प्रकाशित: (2019-09-01) -
Potential markers of response to treatment of patients with chronic spontaneous urticaria
द्वारा: N. O. Pereverzina, और अन्य
प्रकाशित: (2021-06-01) -
Successful Treatment of Chronic Spontaneous Urticaria Associated with Autoimmune Thyroiditis: Clinical Case
द्वारा: Vera G. Kalugina, और अन्य
प्रकाशित: (2019-12-01) -
Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse?
द्वारा: Petek Üstün, और अन्य
प्रकाशित: (2025-07-01) -
Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases
द्वारा: Aset Kh. Ibisheva, और अन्य
प्रकाशित: (2024-12-01)